Shareholder Vote

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549   FORM 8-K   CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 27, 2024     Genesco Inc. (Exact name of Registrant as Specified in Its Charter)     Tennessee 1-3083 62-0211340 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.)           535 Marriott Drive   Nashville , Tennessee   37214 (Address of Principal Executive Offices)   (Zip Code)   Registrant’s Telephone Number, Including Area Code: 615 367-7000     (Former Name or Former Address, if Changed Since Last Report)   Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class   Trading Symbol(s)   Name of each exchange on which registered Common Stock, $1.00 par value   GCO   New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐   Item 5.07 Submission of Matters to a Vote of Security Holders.   The 2024 annual meeting of shareholders of the Company (the “Annual Meeting”) was hosted virtually on June 27, 2024, from the Company’s corporate headquarters in Nashville, Tennessee. Shares representing a total of 11,633,895 votes were outstanding and entitled to vote. At the Annual Meeting, the Company’s shareholders voted on the matters set forth below.   Election of Directors   The Company’s shareholders elected all nine persons nominated for election as directors until the next annual meeting of the shareholders and until their successors are elected and qualified as set forth in the Company’s proxy statement dated May 17, 2024. The following table sets forth the vote of the shareholders at the Annual Meeting with respect to the election of directors:   Nominee For Against Abstain Broker Non-Votes Joanna Barsh 8,350,201 670,688 48,295 445,762 Matthew M. Bilunas 8,718,403 302,483 48,298 445,762 Carolyn Bojanowski 8,685,933 333,756 49,495 445,762 John F. Lambros 8,671,701 349,185 48,298 445,762 Thurgood Marshall, Jr. 8,600,750 430,169 38,365 445,762 Angel R. Martinez 8,684,833 336,053 48,298 445,762 Mary E. Meixelsperger 8,717,693 302,096 49,395 445,762 Gregory A. Sandfort 8,684,964 335,922 48,298 445,762 Mimi E. Vaughn 8,555,915 408,931 104,338 445,762   Non-Binding, Advisory Vote on the Company’s Executive Compensation The Company’s shareholders voted upon a non‑binding, advisory proposal to approve the compensation of the Company’s named executive officers as disclosed in the proxy statement for the Annual Meeting. The votes on this proposal were as follows:   For Against Abstain Broker Non-Votes 8,361,814 596,431 110,939 445,762     Approval of the Genesco Inc. Second Amended and Restated 2020 Equity Incentive Plan The Company's shareholders voted upon and approved the Genesco Inc. Second Amended and Restated 2020 Equity Incentive Plan as disclosed in the proxy statement for the Annual Meeting. The votes on this proposal were as follows: For Against Abstain Broker Non-Votes 8,289,229 733,395 46,560 445,762 Ratification of Independent Accountants The Company’s shareholders voted upon and approved the ratification of the appointment of Ernst & Young LLP to serve as the Company’s independent registered public accounting firm for the current fiscal year. The votes on this proposal were as follows: For Against Abstain 9,364,863 108,367 41,716     SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.       GENESCO, INC.         Date: June 27, 2024 By: /s/Scott E. Becker       Scott E. Becker Senior Vice President, Secretary and General Counsel